Posted by Jay2112 on July 23, 2022, at 19:05:18
In reply to Re: Amur Corktree arrived, posted by SLS on July 23, 2022, at 8:35:37
> > Why would certain MAO-B inhibitors feel different than others?
>
> That's a great question. The answer to that question relies on uncertainty I think we have seen enough counterintuitive responses to drugs on this board. Eventually, what we consider counterintuitive today will be easily explainable in the future as more information is gathered.
>
> In my estimation, a robust response to an MAOI depends the inhibition of MAO-A. The package label for EMSAM explains this explicitly. However, a MAO-B inhibitor called pargyline was used to treat depression for many years before it was withdrawn from market. Nothing was wrong with the drug other than its waning popularity.
>
>
> - ScotttScott, I think what is missing is that companies promote particular drugs as affecting everyone the same way. BUT, genetics makes that almost impossible. They don't take that into account. There are simple genetic tests that show which drugs we are likely to succeed on. I am hoping to get one of those tests done in the next year. Mind you, I have tried pretty much every psychiatric drug available in Canada, so I know which ones work better with me.
Just IMHO, YMMV, etc.
JayHumans punish themselves endlessly
for not being what they believe they should be.
-Don Miguel Ruiz-
poster:Jay2112
thread:1120116
URL: http://www.dr-bob.org/babble/20220530/msgs/1120133.html